Free Trial

Glaukos (GKOS) Competitors

Glaukos logo
$99.25 +3.61 (+3.77%)
Closing price 03:59 PM Eastern
Extended Trading
$100.28 +1.03 (+1.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GKOS vs. PHG, ZBH, SNN, SOLV, PEN, STVN, NARI, IRTC, TMDX, and BLCO

Should you be buying Glaukos stock or one of its competitors? The main competitors of Glaukos include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry.

Glaukos vs.

Glaukos (NYSE:GKOS) and Koninklijke Philips (NYSE:PHG) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk, institutional ownership and community ranking.

Glaukos has higher earnings, but lower revenue than Koninklijke Philips. Glaukos is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glaukos$404.52M13.52-$134.66M-$2.37-40.37
Koninklijke Philips$17.98B1.25-$503.27M$0.4355.43

99.0% of Glaukos shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 5.8% of Glaukos shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Koninklijke Philips had 4 more articles in the media than Glaukos. MarketBeat recorded 8 mentions for Koninklijke Philips and 4 mentions for Glaukos. Glaukos' average media sentiment score of 0.56 beat Koninklijke Philips' score of 0.31 indicating that Glaukos is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Glaukos
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Koninklijke Philips
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Glaukos has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, Koninklijke Philips has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500.

Koninklijke Philips has a net margin of -3.88% compared to Glaukos' net margin of -39.04%. Koninklijke Philips' return on equity of 10.85% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Glaukos-39.04% -16.53% -10.61%
Koninklijke Philips -3.88%10.85%4.45%

Glaukos received 76 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 65.19% of users gave Glaukos an outperform vote while only 56.70% of users gave Koninklijke Philips an outperform vote.

CompanyUnderperformOutperform
GlaukosOutperform Votes
457
65.19%
Underperform Votes
244
34.81%
Koninklijke PhilipsOutperform Votes
381
56.70%
Underperform Votes
291
43.30%

Glaukos currently has a consensus price target of $134.67, suggesting a potential upside of 40.75%. Given Glaukos' higher possible upside, research analysts plainly believe Glaukos is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glaukos
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
Koninklijke Philips
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00

Summary

Glaukos beats Koninklijke Philips on 10 of the 19 factors compared between the two stocks.

Get Glaukos News Delivered to You Automatically

Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GKOS vs. The Competition

MetricGlaukosSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$5.47B$4.38B$5.55B$19.79B
Dividend YieldN/A42.67%5.27%3.84%
P/E Ratio-33.3428.2027.2335.71
Price / Sales13.5270.27423.1845.94
Price / CashN/A51.0838.2517.52
Price / Book10.115.967.124.84
Net Income-$134.66M$67.01M$3.23B$1.02B
7 Day Performance5.15%1.53%3.78%2.29%
1 Month Performance6.38%18.46%13.33%5.86%
1 Year Performance-15.46%19.19%32.07%11.14%

Glaukos Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GKOS
Glaukos
4.5692 of 5 stars
$99.25
+3.8%
$134.67
+35.7%
-15.2%$5.67B$404.52M-34.58780Positive News
PHG
Koninklijke Philips
2.6289 of 5 stars
$22.81
-1.0%
N/A-9.3%$21.44B$17.98B-27.1578,200
ZBH
Zimmer Biomet
4.8544 of 5 stars
$91.12
-1.1%
$111.53
+22.4%
-16.0%$18.03B$7.70B20.4818,000Positive News
SNN
Smith & Nephew
2.338 of 5 stars
$29.17
+0.7%
$28.00
-4.0%
+15.0%$12.78B$5.81B13.5120,100Short Interest ↑
SOLV
Solventum
0.2777 of 5 stars
$73.08
0.0%
$80.29
+9.9%
+33.1%$12.64B$8.31B33.8322,000Positive News
PEN
Penumbra
4.5694 of 5 stars
$256.57
-3.9%
$302.40
+17.9%
+35.8%$9.94B$1.24B754.623,900
STVN
Stevanato Group
1.5457 of 5 stars
€22.01
-0.9%
N/A+32.9%$6.67B$1.12B46.834,650Positive News
NARI
Inari Medical
0.2471 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800News Coverage
IRTC
iRhythm Technologies
1.1969 of 5 stars
$140.65
+0.1%
$133.73
-4.9%
+56.1%$4.49B$618.59M-38.641,790Analyst Forecast
TMDX
TransMedics Group
1.4554 of 5 stars
$123.94
-2.5%
$126.70
+2.2%
-2.6%$4.19B$488.23M131.85210
BLCO
Bausch + Lomb
3.6826 of 5 stars
$11.46
-0.1%
$15.50
+35.3%
-16.2%$4.05B$4.83B-12.5912,500Analyst Forecast

Related Companies and Tools


This page (NYSE:GKOS) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners